Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
53.82M | 55.07M | 36.18M | 14.59M | 9.54M | Gross Profit |
12.23M | 23.08M | 14.60M | 6.72M | 5.01M | EBIT |
-7.23M | 10.30M | 4.43M | 1.17M | 854.34K | EBITDA |
-5.21M | 11.73M | 5.54M | 1.33M | 988.92K | Net Income Common Stockholders |
-6.34M | 8.52M | 4.06M | 911.00K | 432.67K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
6.36M | 3.22M | 4.07M | 4.28M | 3.62M | Total Assets |
47.42M | 48.36M | 28.20M | 11.62M | 6.57M | Total Debt |
6.70M | 7.93M | 191.00K | 5.18M | 2.16M | Net Debt |
333.00K | 4.70M | -3.88M | 899.00K | -1.45M | Total Liabilities |
28.45M | 23.35M | 11.76M | 9.35M | 5.26M | Stockholders Equity |
18.96M | 25.02M | 16.44M | 2.28M | 1.31M |
Cash Flow | Free Cash Flow | |||
5.00M | -4.20M | 392.00K | -1.76M | 1.39M | Operating Cash Flow |
6.39M | -3.04M | 3.66M | 4.74K | 1.43M | Investing Cash Flow |
-1.77M | -2.77M | -8.38M | -1.76M | -40.91K | Financing Cash Flow |
-2.02M | 4.97M | 4.50M | 2.43M | 1.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £327.62M | 10.66 | 13.45% | 2.00% | -6.07% | 41.18% | |
72 Outperform | £690.47M | 16.18 | 10.20% | 3.45% | 8.04% | 6.94% | |
71 Outperform | £8.05B | 34.51 | 17.17% | 4.43% | 5.38% | 86.34% | |
64 Neutral | £7.58B | 66.93 | 5.50% | 4.54% | 8.61% | ― | |
63 Neutral | $8.50B | 10.80 | 5.35% | 4.36% | 3.58% | -11.46% | |
56 Neutral | £2.39B | ― | -4.09% | 7.03% | 20.25% | -128.71% | |
45 Neutral | £8.14M | ― | -47.98% | ― | 1.44% | -251.55% |